ASB vs IBOC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ASB's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability. While growth metrics are strong—evidenced by 20% YoY revenue growth and 30.4% earnings growth—the elevated P/E of 31.86 and a payout ratio exceeding 100% raise sustainability concerns. The stock trades above both the Graham Number ($23.11) and intrinsic value estimate ($24.48), implying overvaluation relative to defensive and growth-based models. Analysts concur with a 'hold' rating, and insider selling adds caution, though solid earnings beats provide some support.
IBOC presents a stable but stagnant profile, characterized by a Piotroski F-Score of 4/9, indicating baseline financial health. While the stock is fundamentally undervalued relative to its Graham Number of $88.26 and analyst target of $87.00, it is hampered by negative year-over-year earnings growth (-7.60%) and a bearish technical trend score of 10/100. The company maintains strong profitability margins and a very sustainable dividend payout, but lacks the growth catalysts necessary for a bullish rating.
Compare Another Pair
Related Comparisons
ASB vs IBOC: Head-to-Head Comparison
This page compares Associated Banc-Corp (ASB) and International Bancshares Corporation (IBOC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.